CRISPR Therapeutics | 48.83 -0.87 -1.75% | ||
| CRSP | |||
| 高 50.63 | 开 49.36 | 量 131.23万股 | 总市值 46.54亿 |
| 低 48.69 | 换 1.38% | 额 6506.03万 | 市盈TTM 亏损 |
分时
5日
日K
周K
月K
季K
年K
CRISPR Therapeutics(CRSP)
02-06 03:15
$CRISPR Therapeutics(CRSP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001562230-26-000001 Act: 34 Size: 7 KB 网页链接
CRISPR Therapeutics(CRSP)
01-28 06:45
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-024955 Size: 5 KB 网页链接
CRISPR Therapeutics(CRSP)
01-27 06:45
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-022845 Size: 8 KB 网页链接
CRISPR Therapeutics(CRSP)
01-23 07:05
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-019733 Size: 9 KB 网页链接
CRISPR Therapeutics(CRSP)
01-23 06:25
$CRISPR Therapeutics(CRSP)$ 144 Report of proposed sale of securities Accession Number: 0001958244-26-000050 Act: 33 Size: 6 KB 网页链接
CRISPR Therapeutics(CRSP)
01-23 05:05
$CRISPR Therapeutics(CRSP)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000625 Act: 33 Size: 6 KB 网页链接
CRISPR Therapeutics(CRSP)
01-21 06:15
$CRISPR Therapeutics(CRSP)$ 144 Report of proposed sale of securities Accession Number: 0001958244-26-000046 Act: 33 Size: 12 KB 网页链接
CRISPR Therapeutics(CRSP)
01-12 21:45
$CRISPR Therapeutics(CRSP)$ 8-K Current report, item 8.01 Accession Number: 0001193125-26-009880 Act: 34 Size: 167 KB 网页链接
CRISPR Therapeutics(CRSP)
01-09 06:45
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-007875 Size: 15 KB 网页链接
CRISPR Therapeutics(CRSP)
01-07 06:15
$CRISPR Therapeutics(CRSP)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000216 Act: 33 Size: 5 KB 网页链接
CRISPR Therapeutics(CRSP)
2025-12-24 06:35
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-331162 Size: 8 KB 网页链接
CRISPR Therapeutics(CRSP)
2025-12-23 06:45
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-329010 Size: 5 KB 网页链接
CRISPR Therapeutics(CRSP)
2025-12-23 05:25
$CRISPR Therapeutics(CRSP)$ 144 Report of proposed sale of securities Accession Number: 0001950047-25-010601 Act: 33 Size: 5 KB 网页链接
CRISPR Therapeutics(CRSP)
2025-11-15 01:35
$CRISPR Therapeutics(CRSP)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0000940594-25-000008 Act: 34 Size: 16 KB 网页链接
1赞
CRISPR Therapeutics(CRSP)
2025-11-10 21:25
$CRISPR Therapeutics(CRSP)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-273337 Act: 34 Size: 9 MB 网页链接
CRISPR Therapeutics(CRSP)
2025-11-10 21:15
$CRISPR Therapeutics(CRSP)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-25-273329 Act: 34 Size: 428 KB 网页链接
CRISPR Therapeutics(CRSP)
2025-11-05 05:55
$CRISPR Therapeutics(CRSP)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-106355 Act: 34 Size: 13 KB 网页链接
CRISPR Therapeutics(CRSP)
2025-10-21 05:45
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-243819 Size: 9 KB 网页链接
CRISPR Therapeutics(CRSP)
2025-10-16 05:45
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-240437 Size: 8 KB 网页链接
CRISPR Therapeutics(CRSP)
2025-10-16 05:45
$CRISPR Therapeutics(CRSP)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-240438 Size: 9 KB 网页链接